-Bloomberg
Recap: Concert Pharmaceuticals Q4 Earnings
Concert Pharmaceuticals (NASDAQ:CNCE) reported its Q4 earnings results on Thursday, March 3, 2022 at 07:00 AM.
Here's what investors need to know about the announcement.
Related Posts
Raymond James Maintains Strong Buy on National Retail Props, Lowers Price Target to $52
Raymond James analyst RJ Milligan maintains National Retail Props (NYSE:NNN) with a Strong Buy and lowers the price target from $55 to $52.
Charah Solutions Press Release From Thursday Evening Highlights Co. ‘Stands Ready to Assist Utility Partners in Meeting EPA Regulations for Approximately 1,000 Regulatory Mandated Coal Ash Surface Impoundments and Landfills’
https://www.accesswire.com/683478/Charah-Solutions-Stands-Ready-to-Assist-Utility-Partners-in-Meeting-EPA-Regulations-for-Approximately-1000-Regulatory-Mandated-Coal-Ash-Surface-Impoundments-and-Landfills-Needing-Remediation-or-Closure
RBC Capital Maintains Outperform on AMETEK, Raises Price Target to $135
RBC Capital analyst Deane Dray maintains AMETEK (NYSE:AME) with a Outperform and raises the price target from $134 to $135.